Peter Jackson

Colossal Raises Another $120M, Announces Pigeon Cell Breakthrough to Help ‘De‑Extinct’ the Dodo

by | Sep 17, 2025
Dallas-based Colossal Biosciences announced an add-on Series C raise that values it at $10.32 billion. Meanwhile, eggs are being laid in Texas to help advance the "de-extinction" of the famously extinct dodo bird—with a little help from the Nicobar pigeon, the dodo's closest living relative.
MORE
Builders FirstSource Names New President of Technology and Digital Solutions
by | Jul 2, 2025
The Dallas-based building materials giant says Gayatri Narayan's hire will help accelerate digital and technical innovation for long-term growth.
MORE
The Last Word: Colossal Biosciences’ Ben Lamm on Science, Skeptics, and the Sound of a Howl
by | Jun 5, 2025
In one of his first deep interviews since Colossal's dire wolf debut made global noise, Ben Lamm joins the TechStuff podcast to talk mammoths, backlash, and why he's not here to play it safe.
MORE
Dallas’ Colossal Biosciences Becomes Texas’ First Decacorn, Securing $10.2B Valuation With Series C Funding
by | Jan 15, 2025
Best known for its moonshot mission to revive the woolly mammoth, Colossal Biosciences has secured $200 million in Series C funding led by TWG Global. The world's first de-extinction company, founded in 2021 by entrepreneur Ben Lamm and renowned Harvard geneticist George Church, Colossal Biosciences is working to restore Earth's lost biodiversity, "making science fiction into science fact."
MORE